Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | ONCOLOGY//CELL BIOLOGY//BIOCHEMISTRY & MOLECULAR BIOLOGY | 2934640 |
432 | 3 | TRAIL//SURVIVIN//APOPTOSIS | 28744 |
258 | 2 | TRAIL//SURVIVIN//APOPTOSIS | 19509 |
4426 | 1 | MCL 1//BH3 MIMETIC//ABT 737 | 1820 |
Terms with highest relevance score |
rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|---|
1 | MCL 1 | authKW | 1729517 | 14% | 39% | 256 |
2 | BH3 MIMETIC | authKW | 839584 | 4% | 65% | 75 |
3 | ABT 737 | authKW | 825657 | 5% | 58% | 82 |
4 | OBATOCLAX | authKW | 407984 | 2% | 65% | 36 |
5 | NOXA | authKW | 277419 | 3% | 32% | 50 |
6 | ABT 263 | authKW | 252431 | 1% | 54% | 27 |
7 | BIM | authKW | 246496 | 5% | 14% | 99 |
8 | PUMA | authKW | 226601 | 4% | 18% | 71 |
9 | NAVITOCLAX | authKW | 200153 | 1% | 68% | 17 |
10 | BH3 ONLY PROTEINS | authKW | 191043 | 2% | 32% | 35 |
Web of Science journal categories |
chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | Oncology | 9199 | 38% | 0% | 683 |
2 | Cell Biology | 7015 | 32% | 0% | 590 |
3 | Biochemistry & Molecular Biology | 1958 | 30% | 0% | 541 |
4 | Hematology | 1477 | 9% | 0% | 170 |
5 | Chemistry, Medicinal | 910 | 7% | 0% | 133 |
6 | Genetics & Heredity | 231 | 6% | 0% | 111 |
7 | Medicine, Research & Experimental | 135 | 4% | 0% | 81 |
8 | Pharmacology & Pharmacy | 126 | 8% | 0% | 137 |
9 | Immunology | 55 | 5% | 0% | 83 |
10 | Developmental Biology | 23 | 1% | 0% | 20 |
Address terms |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | MOL GENET CANC | 110391 | 1% | 26% | 25 |
2 | TEAM CELL SURVIVAL TUMOR ESC E BREAST CANC 8 | 51940 | 0% | 50% | 6 |
3 | PLATEFORME IMPACT | 46171 | 0% | 67% | 4 |
4 | TENI | 39574 | 0% | 57% | 4 |
5 | BIOGENOUEST RECH THER EUT | 38958 | 0% | 75% | 3 |
6 | EQUIPE ELISEE LIGUE 5 | 34630 | 0% | 100% | 2 |
7 | SCOTT WHITE MEM HOSP CLIN SURG | 34630 | 0% | 100% | 2 |
8 | UMR S965 | 34630 | 0% | 100% | 2 |
9 | DEV IMMUNOL | 33425 | 2% | 5% | 36 |
10 | UMR601 | 27699 | 0% | 40% | 4 |
Journals |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | CELL DEATH AND DIFFERENTIATION | 28597 | 4% | 2% | 74 |
2 | CELL DEATH & DISEASE | 11448 | 2% | 2% | 42 |
3 | MOLECULAR CANCER THERAPEUTICS | 6212 | 2% | 1% | 39 |
4 | ONCOTARGET | 4127 | 3% | 0% | 63 |
5 | APOPTOSIS | 3258 | 1% | 1% | 15 |
6 | BLOOD | 3237 | 5% | 0% | 82 |
7 | ONCOGENE | 3072 | 3% | 0% | 58 |
8 | CANCER BIOLOGY & THERAPY | 2633 | 1% | 1% | 21 |
9 | PEZCOLLER FOUNDATION SYMPOSIA | 2467 | 1% | 1% | 12 |
10 | CANCER CELL | 2430 | 1% | 1% | 15 |
Author Key Words |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass | LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | MCL 1 | 1729517 | 14% | 39% | 256 | Search MCL+1 | Search MCL+1 |
2 | BH3 MIMETIC | 839584 | 4% | 65% | 75 | Search BH3+MIMETIC | Search BH3+MIMETIC |
3 | ABT 737 | 825657 | 5% | 58% | 82 | Search ABT+737 | Search ABT+737 |
4 | OBATOCLAX | 407984 | 2% | 65% | 36 | Search OBATOCLAX | Search OBATOCLAX |
5 | NOXA | 277419 | 3% | 32% | 50 | Search NOXA | Search NOXA |
6 | ABT 263 | 252431 | 1% | 54% | 27 | Search ABT+263 | Search ABT+263 |
7 | BIM | 246496 | 5% | 14% | 99 | Search BIM | Search BIM |
8 | PUMA | 226601 | 4% | 18% | 71 | Search PUMA | Search PUMA |
9 | NAVITOCLAX | 200153 | 1% | 68% | 17 | Search NAVITOCLAX | Search NAVITOCLAX |
10 | BH3 ONLY PROTEINS | 191043 | 2% | 32% | 35 | Search BH3+ONLY+PROTEINS | Search BH3+ONLY+PROTEINS |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |